BioMarin Pharmaceutical Inc. Stock Performance

Open $54.76	Prev. Close $54.88	Circuit Range N/A
Day Range $54.50 - $55.98	Year Range $49.29 - $70.98	Volume 83,897
Average Traded $55.04

BioMarin Pharmaceutical Inc. Share Price Today

As of 11 October 2026, BioMarin Pharmaceutical Inc.'s share price is $54.80. The stock opened at $54.76, compared to its previous close of $54.88. During today's trading session, BioMarin Pharmaceutical Inc.'s share price traded between $54.50 and $55.98, with an average price of $55.24. Over the past 52 weeks, the stock has recorded a high of $70.98 and a low of $49.29. In terms of performance, BioMarin Pharmaceutical Inc.'s share price has risen by 1.62% over the last six months and is up 2.24% on a year-on-year basis.

BioMarin Pharmaceutical Inc. Share Price Chart

$54.50$55.98

BioMarin Pharmaceutical Inc. Stock Fundamentals & Key Indicators

Market Cap $10.51B	PE Ratio (TTM) 145.37	Dividend Yield 0.00%
EPS (TTM) $0.38	Revenue (TTM) $3.22T	Return On Equity (TTM) 1.15%
Profit Margin 10.83%	Debt to Equity 0.66	Quarterly Earnings Growth YoY 245.61%

BioMarin Pharmaceutical Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$776.13	$874.57	$766.21	$989.71
Net Profit	-$30.74	-$46.57	$105.53	$44.76
Net Profit Margin	-3.96%	-5.32%	13.77%	4.52%
Income Change	N/A	-51.50%	326.61%	-57.59%

BioMarin Pharmaceutical Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$2096.04	$2419.23	$2853.92	$3221.25
Net Profit	$141.56	$167.65	$426.86	$348.90
Net Profit Margin	6.75%	6.93%	14.96%	10.83%
Income Change	N/A	18.43%	154.61%	-18.26%

About BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

BioMarin Pharmaceutical Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$59.81	$54.83	-8.68%
Sep 2026	$65.58	$60.04	-8.07%
Aug 2026	$60.41	$65.31	+8.81%
Jul 2026	$57.46	$60.02	+4.86%
Jun 2026	$56.67	$57.24	-0.16%
May 2026	$53.84	$57.33	+6.31%
Apr 2026	$56.91	$53.92	-4.52%
Mar 2026	$60.77	$56.48	-8.49%
Feb 2026	$56.52	$61.72	+9.17%
Jan 2026	$59.05	$56.53	-4.89%
Dec 2025	$55.56	$59.44	+6.33%
Nov 2025	$53.27	$55.90	+4.29%

BMRN Share Price FAQs

What is BioMarin Pharmaceutical Inc. share price today?

BioMarin Pharmaceutical Inc. share price today is $54.80 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of BioMarin Pharmaceutical Inc. stock?

The 52 week high of BioMarin Pharmaceutical Inc. stock is $70.98, while the 52 week low is $49.29 as of 10 Oct '26.

What is BMRN's market capitalisation today?

BMRN market capitalisation is $10.51B as of October 11, 2026, at 4:15 am IST.

What is BMRN's net income for the last quarter?

BMRN's net income for the last quarter is 44.76B USD.

What is the 5 year returns of BMRN?

The 5 year returns of BMRN is -30.87% as on 10 Oct '26.

What is the high & low stock price of BMRN today?

BMRN stock price hit a high of $55.98 and low of $54.50 as of 10 Oct '26.

Can I buy BMRN shares in India?

Yes. You can buy BMRN in India by opening an international trading account.